Also trades as: EIGRQ (OTC) · $vol 0M
EIGR NASDAQ
Eiger BioPharmaceuticals, Inc.
1W: -35.7%
1M: +0.0%
3M: -70.0%
1Y: -95.0%
3Y: -99.3%
5Y: -99.5%
$1.73
Last traded 2025-06-17 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships0
As Filer
counterparties named
3
As Counterparty
mentioned by others
2024-06-18
Earliest Filing
2024-07-10
Latest Filing
Mentioned As Counterparty
3 mentionsOther companies that named EIGR in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| AMLX Amylyx Pharmaceuticals, Inc. | acquirer | Sold Avexitide asset rights to Amylyx Pharmaceuticals, Inc. | 2024-07-10 | View |
| AMLX Amylyx Pharmaceuticals, Inc. | acquirer | Sold substantially all assets related to Avexitide to Amylyx Pharmaceuticals, Inc. | 2024-06-21 | View |
| SPRB SPRUCE BIOSCIENCES, INC. | acquirer | Seller of Avexitide assets in a stalking horse asset purchase agreement. | 2024-06-18 | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR